These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20057179)

  • 1. [Anti-viral treatment for liver cirrhosis].
    Ikeda K
    Nihon Shokakibyo Gakkai Zasshi; 2010 Jan; 107(1):8-13. PubMed ID: 20057179
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy of hepatitis B and C].
    Färkkilä M
    Duodecim; 2003; 119(6):519-29. PubMed ID: 12708339
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of the patient with hepatitis B virus-related cirrhosis.
    Perrillo RP
    J Hepatol; 2003; 39 Suppl 1():S177-80. PubMed ID: 14708700
    [No Abstract]   [Full Text] [Related]  

  • 4. Lamivudine therapy of hepatitis B virus-related liver disease: cirrhosis, posttransplantation recurrence, and de novo infection.
    Bárcena R; Domínguez-Antonaya M; López-Sanromán A; Martínez-Turnes A; Urman J; del Campo S; Moreno N
    Transplant Proc; 1999 Sep; 31(6):2457-8. PubMed ID: 10500669
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of patients with decompensated HBV cirrhosis.
    Fontana RJ
    Semin Liver Dis; 2003 Feb; 23(1):89-100. PubMed ID: 12616454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation.
    Herrero JI; Quiroga J; Sangro B; Sola I; Riezu-Boj JI; Pardo F; Prieto J
    Dig Dis Sci; 1998 Jun; 43(6):1186-9. PubMed ID: 9635605
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection.
    Marrone A; Zampino R; D'Onofrio M; Ricciotti R; Ruggiero G; Utili R
    J Hepatol; 2004 Dec; 41(6):1064-5. PubMed ID: 15582146
    [No Abstract]   [Full Text] [Related]  

  • 8. Lamivudine therapy for decompensated liver cirrhosis related to hepatitis B virus infection.
    Lee HC; Suh DJ
    Intervirology; 2003; 46(6):388-93. PubMed ID: 14688457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamivudine treatment in patients with decompensated hepatitis B cirrhosis: for whom and when?
    Fontana RJ; Lok AS
    J Hepatol; 2000 Aug; 33(2):329-32. PubMed ID: 10952253
    [No Abstract]   [Full Text] [Related]  

  • 10. Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B.
    Hanada S; Kumashiro R; Kaji R; Harada M; Sata M
    Int J Mol Med; 2002 Nov; 10(5):647-8. PubMed ID: 12373309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.
    Zhang FK
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):10-5. PubMed ID: 16481275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance.
    Andreone P; Gramenzi A; Cursaro C; Biselli M; Cammà C; Trevisani F; Bernardi M
    J Viral Hepat; 2004 Sep; 11(5):439-42. PubMed ID: 15357649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of liver cirrhosis due to hepatitis B with lamivudine].
    Castellano G; Fernández I; Jiménez C; Solís Herruzo JA
    Gastroenterol Hepatol; 1999 Oct; 22(8):433-4. PubMed ID: 10592680
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma.
    Hiraoka A; Michitaka K; Kumagi T; Kurose K; Uehara T; Hirooka M; Yamashita Y; Kubo Y; Miyaoka H; Iuchi H; Okada S; Ohmoto M; Yamamoto K; Horiike N; Onji M
    Oncol Rep; 2005 Jun; 13(6):1159-63. PubMed ID: 15870937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies about the treatment of hepatitis B (lamivudine, interferon, a combination or more?).
    Desai HG; Chowdhury A
    Trop Gastroenterol; 2003; 24(3):157-60. PubMed ID: 14978995
    [No Abstract]   [Full Text] [Related]  

  • 16. [HVB and HVC infections in nephrology].
    Pol S
    Nephrologie; 2001; 22(6):321-2. PubMed ID: 11715611
    [No Abstract]   [Full Text] [Related]  

  • 17. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort.
    Yao FY; Terrault NA; Freise C; Maslow L; Bass NM
    Hepatology; 2001 Aug; 34(2):411-6. PubMed ID: 11481627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis.
    Schiano TD; Lissoos TW; Ahmed A; Siano C; Zaitman D; Cohn G; Ehrenpreis ED
    Am J Gastroenterol; 1997 Sep; 92(9):1563-4. PubMed ID: 9317091
    [No Abstract]   [Full Text] [Related]  

  • 19. A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis.
    Hann HW; Fontana RJ; Wright T; Everson G; Baker A; Schiff ER; Riely C; Anschuetz G; Gardner SD; Brown N; Griffiths D;
    Liver Transpl; 2003 Jan; 9(1):49-56. PubMed ID: 12514773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Consensus document of the Spanish Association for the Study of the Liver on the treatment of hepatitis B infection (2012)].
    Buti M; García-Samaniego J; Prieto M; Rodríguez M; Sánchez-Tapias JM; Suárez E; Esteban R
    Gastroenterol Hepatol; 2012; 35(7):512-28. PubMed ID: 22749508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.